Genetics and variable drug response
- PMID: 21771992
- PMCID: PMC3539154
- DOI: 10.1001/jama.2011.998
Genetics and variable drug response
Conflict of interest statement
References
-
- Epstein RS, Moyer TP, Aubert RE, et al. Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study) J Am Coll Cardiol. 2010;55(25):2804–2812. - PubMed
-
- Chen P, Lin JJ, Lu CS, et al. Taiwan SJS Consortium. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med. 2011;364(12):1126–1133. - PubMed
Publication types
MeSH terms
Grants and funding
- CA136765/CA/NCI NIH HHS/United States
- R01DK080007/DK/NIDDK NIH HHS/United States
- U01 GM061393/GM/NIGMS NIH HHS/United States
- P50 CA125183/CA/NCI NIH HHS/United States
- R01 CA136765/CA/NCI NIH HHS/United States
- U19HL065962/HL/NHLBI NIH HHS/United States
- R01 DK080007/DK/NIDDK NIH HHS/United States
- U19 HL069757/HL/NHLBI NIH HHS/United States
- U01HL069757/HL/NHLBI NIH HHS/United States
- U01 HL069757/HL/NHLBI NIH HHS/United States
- U19 HL065962/HL/NHLBI NIH HHS/United States
- U01GM61393/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical